Literature DB >> 16314087

Clinical factors associated with fatigue in haematologic cancer patients receiving stem-cell transplantation.

Jesús M Prieto1, Jordi Blanch, Jorge Atala, Enric Carreras, Montserrat Rovira, Esteve Cirera, Cristobal Gastó.   

Abstract

We have evaluated risk factors associated with fatigue in 220 cancer patients during hospitalization for stem-cell transplantation (SCT). Fatigue was assessed using a validated one-item energy scale and a comprehensive set of fatigue predictors, at hospital admission (baseline), day of SCT, and 7 days and 14 days after SCT. In cross-sectional multivariate analysis, depression was the variable most consistently and strongly associated with fatigue; other factors significantly associated with fatigue at some time during the study included older age, higher education, smoking, lower Karnofsky performance status, loss of appetite, nausea/vomiting, pain, higher regimen-related toxicity, low hemoglobin level, requirement for red blood-cell transfusions, and third year of the study period. In prospective multivariate analysis, baseline depression showed significance or a trend towards significance in its ability to predict subsequent measures of fatigue during hospitalization. Our findings may help to shed light on the mechanisms underlying fatigue and may also guide future interventions.

Entities:  

Mesh:

Year:  2005        PMID: 16314087     DOI: 10.1016/j.ejca.2005.10.005

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  8 in total

1.  Pilot randomized controlled trial of a patient-controlled cognitive-behavioral intervention for the pain, fatigue, and sleep disturbance symptom cluster in cancer.

Authors:  Kristine L Kwekkeboom; Kristen Abbott-Anderson; Catherine Cherwin; Rachel Roiland; Ronald C Serlin; Sandra E Ward
Journal:  J Pain Symptom Manage       Date:  2012-07-07       Impact factor: 3.612

Review 2.  Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature.

Authors:  Catherine E Mosher; William H Redd; Christine M Rini; Jack E Burkhalter; Katherine N DuHamel
Journal:  Psychooncology       Date:  2009-02       Impact factor: 3.894

3.  Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S.

Authors:  David H Henry; Hema N Viswanathan; Eric P Elkin; Shana Traina; Shawn Wade; David Cella
Journal:  Support Care Cancer       Date:  2008-01-17       Impact factor: 3.603

Review 4.  Cancer-related fatigue and its associations with depression and anxiety: a systematic review.

Authors:  Linda F Brown; Kurt Kroenke
Journal:  Psychosomatics       Date:  2009 Sep-Oct       Impact factor: 2.386

5.  The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT).

Authors:  Margaret F Bevans; Sandra A Mitchell; Susan Marden
Journal:  Support Care Cancer       Date:  2008-03-06       Impact factor: 3.603

6.  Prevalence and determinants of fatigue in patients with moderate to severe chronic GvHD.

Authors:  A Im; S A Mitchell; S M Steinberg; L Curtis; A Berger; K Baird; Z Kuzmina; G Joe; L E Comis; M Juckett; D Avila; J Baruffaldi; L Masuch; F Pirsl; S Z Pavletic
Journal:  Bone Marrow Transplant       Date:  2016-02-01       Impact factor: 5.483

7.  Clinically Significant Fatigue in Adult Leukemia Patients: Prevalence, Predictors, and Impact on Quality of Life.

Authors:  Isamme AlFayyad; Mohamad Al-Tannir; Muawiyah Yaqub; Humariyah Heena; Nawaf AlMukaibil; Mohammed Ghazwani; Amani Abu-Shaheen
Journal:  Cureus       Date:  2020-12-23

8.  Everyday life following hematopoietic stem cell transplantation: decline in physical symptoms within the first month and change-related predictors.

Authors:  Aleksandra Kroemeke; Małgorzata Sobczyk-Kruszelnicka; Zuzanna Kwissa-Gajewska
Journal:  Qual Life Res       Date:  2017-09-12       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.